JT
Jetra Therapeutics is developing a therapeutic approach to treat obesity-related liver disease by targeting cellular stress mechanisms in hepatocytes. This treatment aims to improve liver function and reduce the risk of complications associated with fatty liver disease.
Updated 20 months ago
Funding
$1.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
IGFunding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Jetra Therapeutics is developing a therapeutic approach to treat obesity-related liver disease by targeting cellular stress mechanisms in hepatocytes. This treatment aims to improve liver function and reduce the risk of complications associated with fatty liver disease.